Olimel 5.7% E 5.58 g (l-Arginine EMULSION) 5.58 G

OlimeL 5.7% E 5.58 G is an intravenous emulsion containing L-arginine, designed for nutritional support. This product, manufactured by Baxter Corporation in Canada, is available in various pack sizes for flexible administration.

Strength

5.58 G

Pack Size

1000/1500/2000/2500ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OlimeL 5.7% E 5.58 G is primarily used for intravenous nutrition, providing essential amino acids like L-arginine. It supports patients who require nutritional support due to various medical conditions. This emulsion is often used in clinical settings to help maintain or improve nutritional status.

Side Effects

When administered intravenously, OlimeL 5.7% E 5.58 G provides essential nutrients directly into the bloodstream. This can help support overall health and recovery, particularly in patients who cannot consume nutrients orally. The emulsion is designed to be well-tolerated, but individual responses may vary.

Precautions & Warnings

OlimeL 5.7% E 5.58 G should be administered under medical supervision. It is important to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

OlimeL 5.7% E 5.58 G may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Additionally, interactions with other intravenous solutions or nutrients should be considered.

Frequently Asked Questions

OlimeL 5.7% E 5.58 G is used for intravenous nutrition, providing essential amino acids like L-arginine to support patients who require nutritional support.

OlimeL 5.7% E 5.58 G is administered intravenously, typically in a clinical setting under medical supervision.

OlimeL 5.7% E 5.58 G provides essential nutrients directly into the bloodstream, supporting overall health and recovery.

OlimeL 5.7% E 5.58 G should be administered under medical supervision and proper handling guidelines should be followed.

OlimeL 5.7% E 5.58 G may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.